Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Phase 1 Study of SGN-CD228A in Select Advanced Solid Tumors

NCT04042480 is registered in ClinicalTrials.gov with Seagen Inc. as lead sponsor.

NCT NCT04042480
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04042480 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Phase 1 Study of SGN-CD228A in Select Advanced Solid Tumors
Lead sponsor
Seagen Inc.
Phase
Phase 1
Overall status
Terminated
Start date
September 3, 2019
Completion date
March 9, 2023
Enrollment
88 (actual)
Sites
14

Conditions

As the registry lists them; a condition with its own page is linked.

colorectal cancer, cutaneous melanoma, her2 negative breast neoplasms, non-small cell lung cancer, pancreatic ductal adenocarcinoma, pleural mesothelioma